Vault-13

Arrowpoint Investment Partners (Singapore) Pte. Ltd.

SINGAPORE, U0 · CIK 2032331 · 13F filing filed 2026-08-13

Exempt reporting adviser since 2024 · other (specify)

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Singapore (main office)Singapore Singapore
WanchaiHong Kong Hong Kong19
DubaiUnited Arab Emirates United Arab Emirates9

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$339.9m reported value +394.4% vs Q1 2026
124positions
63.9%in top 10
82 new 23 added 19 reduced 35 sold out vs Q1 2026

Options: 3 call positions ($89.6m notional), 2 put positions ($29.5m notional) – listed below, not included above.

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CITIGROUP INC COM NEW C C 235,033 $32.9m9.68% 9.68% NewShares held: Q3 2025 0, Q4 2025 464.0k, Q1 2026 0, Q2 2026 235.0k
2 GOLDMAN SACHS GROUP INC COM GS GS 30,971 $31.3m9.21% 9.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 31.0k
3 GLOBAL PMTS INC COM GPN GPN 384,114 $27.9m8.20% 8.20% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 384.1k
4 NORFOLK SOUTHN CORP COM NSC NSC 81,332 $25.6m7.53% 7.53% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 81.3k
5 AMERICAN ELEC PWR CO INC COM AEP AEP 185,962 $25.4m7.48% 7.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 186.0k
6 NVIDIA CORPORATION COM NVDA NVDA 125,539 $25.1m7.39% 7.39% NewShares held: Q3 2025 2.0k, Q4 2025 442.1k, Q1 2026 0, Q2 2026 125.5k
7 EXXON MOBIL CORP COM XOM XOM 179,273 $24.5m7.21% 7.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 179.3k
8 ALPHABET INC CAP STK CL A GOOGL GOOGL 34,557 $12.3m3.63% 3.63% AddedShares held: Q3 2025 0, Q4 2025 1.4k, Q1 2026 31.1k, Q2 2026 34.6k +3.4k +3,430 11.0%
9 MICRON TECHNOLOGY INC COM MU MU 6,519 $7.5m2.21% 2.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.5k
10 INTEL CORP COM INTC INTC 33,371 $4.7m1.37% 1.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 33.4k
11 SANDISK CORP COM SNDK SNDK 2,008 $4.6m1.34% 1.34% NewShares held: Q3 2025 0, Q4 2025 5.9k, Q1 2026 0, Q2 2026 2.0k
12 ARGENX SE SPONSORED ADR ARGX ARGX 4,392 $4.1m1.20% 1.20% NewShares held: Q3 2025 486, Q4 2025 0, Q1 2026 0, Q2 2026 4.4k
13 INFOSYS LTD SPONSORED ADR INFY INFY 367,077 $3.9m1.13% 1.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 367.1k
14 CATERPILLAR INC COM CAT CAT 3,539 $3.8m1.11% 1.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.5k
15 AXSOME THERAPEUTICS INC COM AXSM AXSM 13,831 $3.4m1.00% 1.00% ReducedShares held: Q3 2025 0, Q4 2025 2.1k, Q1 2026 16.4k, Q2 2026 13.8k -2.6k -2,570 -15.7%
16 INSMED INC COM PAR $.01 INSM INSM 30,170 $3.2m0.95% 0.95% AddedShares held: Q3 2025 0, Q4 2025 11.6k, Q1 2026 7.0k, Q2 2026 30.2k +23.2k +23,152 329.9%
17 UNITEDHEALTH GROUP INC COM UNH UNH 7,657 $3.2m0.94% 0.94% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.2k, Q2 2026 7.7k +2.4k +2,441 46.8%
18 BRUKER CORP COM BRKR BRKR 52,780 $3.2m0.93% 0.93% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 52.8k
19 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 5,865 $3.1m0.93% 0.93% AddedShares held: Q3 2025 792, Q4 2025 371, Q1 2026 1.2k, Q2 2026 5.9k +4.7k +4,673 392.0%
20 TRAVERE THERAPEUTICS INC COM TVTX TVTX 55,112 $3.1m0.92% 0.92% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 55.1k
21 HUMANA INC COM HUM HUM 7,839 $3.1m0.92% 0.92% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 7.8k
22 ELI LILLY & CO COM LLY LLY 2,548 $3.1m0.90% 0.90% AddedShares held: Q3 2025 0, Q4 2025 9.2k, Q1 2026 442, Q2 2026 2.5k +2.1k +2,106 476.5%
23 REVVITY INC COM RVTY RVTY 27,316 $3.0m0.89% 0.89% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 27.3k
24 PTC THERAPEUTICS INC COM PTCT PTCT 36,873 $3.0m0.88% 0.88% ReducedShares held: Q3 2025 3.3k, Q4 2025 9.2k, Q1 2026 39.7k, Q2 2026 36.9k -2.8k -2,828 -7.1%
25 ABBVIE INC COM ABBV ABBV 11,928 $3.0m0.88% 0.88% NewShares held: Q3 2025 0, Q4 2025 8.0k, Q1 2026 0, Q2 2026 11.9k
26 CHEMED CORP NEW COM CHE CHE 6,365 $3.0m0.87% 0.87% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.4k
27 ISHARES TR ISHARES SEMICDTR SOXX SOXX 4,590 $2.9m0.87% 0.87% NewShares held: Q3 2025 0, Q4 2025 1.0k, Q1 2026 0, Q2 2026 4.6k
28 AGILENT TECHNOLOGIES INC COM A A 21,826 $2.9m0.85% 0.85% NewShares held: Q3 2025 5.8k, Q4 2025 0, Q1 2026 0, Q2 2026 21.8k
29 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 16,490 $2.8m0.82% 0.82% ReducedShares held: Q3 2025 0, Q4 2025 3.5k, Q1 2026 21.6k, Q2 2026 16.5k -5.1k -5,066 -23.5%
30 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 81,993 $2.8m0.82% 0.82% AddedShares held: Q3 2025 0, Q4 2025 152.7k, Q1 2026 25.8k, Q2 2026 82.0k +56.2k +56,188 217.7%
31 ASTERA LABS INC COM ALAB ALAB 5,293 $2.6m0.75% 0.75% NewShares held: Q3 2025 17.4k, Q4 2025 0, Q1 2026 0, Q2 2026 5.3k
32 COOPER COS INC COM COO COO 34,743 $2.5m0.73% 0.73% AddedShares held: Q3 2025 0, Q4 2025 10.4k, Q1 2026 5.9k, Q2 2026 34.7k +28.8k +28,847 489.3%
33 TWIST BIOSCIENCE CORP COM TWST TWST 20,287 $2.1m0.61% 0.61% AddedShares held: Q3 2025 0, Q4 2025 10.0k, Q1 2026 13.5k, Q2 2026 20.3k +6.8k +6,811 50.5%
34 QUALCOMM INC COM QCOM QCOM 11,141 $2.1m0.61% 0.61% NewShares held: Q3 2025 0, Q4 2025 312.6k, Q1 2026 0, Q2 2026 11.1k
35 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 66,843 $2.0m0.58% 0.58% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 66.8k
36 DAVITA INC COM DVA DVA 8,046 $1.8m0.53% 0.53% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.0k
37 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 5,588 $1.7m0.49% 0.49% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.6k
38 CONCENTRA GROUP HOLDINGS PAR COMMON STOCK CON CON 52,747 $1.6m0.46% 0.46% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 52.7k
39 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 27,041 $1.5m0.46% 0.46% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 48.7k, Q2 2026 27.0k -21.7k -21,678 -44.5%
40 BIOGEN INC COM BIIB BIIB 6,838 $1.5m0.43% 0.43% AddedShares held: Q3 2025 0, Q4 2025 2.9k, Q1 2026 4.7k, Q2 2026 6.8k +2.1k +2,132 45.3%
41 OSCAR HEALTH INC CL A OSCR OSCR 51,105 $1.5m0.43% 0.43% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 51.1k
42 LAM RESEARCH CORP COM NEW LRCX LRCX 3,230 $1.4m0.41% 0.41% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.2k
43 SELECT SECTOR SPDR TR SBI HEALTHCARE XLV XLV 8,600 $1.4m0.40% 0.40% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.6k
44 AVANTOR INC COM AVTR AVTR 131,088 $1.3m0.38% 0.38% NewShares held: Q3 2025 37.9k, Q4 2025 0, Q1 2026 0, Q2 2026 131.1k
45 RAMBUS INC DEL COM RMBS RMBS 9,559 $1.3m0.37% 0.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.6k
46 ISHARES INC MSCI TAIWAN ETF EWT EWT 11,100 $1.2m0.35% 0.35% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 12.5k, Q2 2026 11.1k -1.4k -1,400 -11.2%
47 REVOLUTION MEDICINES INC COM RVMD RVMD 6,100 $1.1m0.34% 0.34% ReducedShares held: Q3 2025 4.4k, Q4 2025 3.2k, Q1 2026 8.0k, Q2 2026 6.1k -1.9k -1,871 -23.5%
48 MODERNA INC COM MRNA MRNA 14,841 $1.0m0.31% 0.31% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 17.1k, Q2 2026 14.8k -2.3k -2,256 -13.2%
49 BRIDGEBIO PHARMA INC COM BBIO BBIO 13,454 $1.0m0.29% 0.29% AddedShares held: Q3 2025 0, Q4 2025 2.9k, Q1 2026 5.8k, Q2 2026 13.5k +7.7k +7,669 132.6%
50 IONIS PHARMACEUTICALS INC COM IONS IONS 12,338 $978.3k0.29% 0.29% ReducedShares held: Q3 2025 5.5k, Q4 2025 25.0k, Q1 2026 39.0k, Q2 2026 12.3k -26.6k -26,650 -68.3%
51 SELECT SECTOR SPDR TR SBI INT-UTILS XLU XLU 20,800 $943.1k0.28% 0.28% AddedShares held: Q3 2025 9.2k, Q4 2025 51.7k, Q1 2026 16.4k, Q2 2026 20.8k +4.4k +4,400 26.8%
52 INVESCO EXCH TRADED FD TR II NASDAQ 100 ETF QQQM QQQM 3,100 $939.2k0.28% 0.28% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.1k
53 SELECT SECTOR SPDR TR RL EST SEL SEC XLRE XLRE 20,000 $880.6k0.26% 0.26% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 20.0k
54 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 2,461 $823.9k0.24% 0.24% ReducedShares held: Q3 2025 0, Q4 2025 2.1k, Q1 2026 3.9k, Q2 2026 2.5k -1.4k -1,394 -36.2%
55 NATERA INC COM NTRA NTRA 2,814 $763.9k0.22% 0.22% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 3.0k, Q2 2026 2.8k -156 -156 -5.2%
56 CYTOKINETICS INC COM NEW CYTK CYTK 8,836 $752.7k0.22% 0.22% AddedShares held: Q3 2025 0, Q4 2025 4.5k, Q1 2026 7.4k, Q2 2026 8.8k +1.4k +1,448 19.6%
57 ISHARES TR 20 YR TR BD ETF TLT TLT 8,700 $751.9k0.22% 0.22% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 7.1k, Q2 2026 8.7k +1.6k +1,600 22.5%
58 SPDR SER TR S&P REGL BKG KRE KRE 10,000 $748.5k0.22% 0.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.0k
59 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 28,725 $726.7k0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 10.0k, Q1 2026 0, Q2 2026 28.7k
60 WESTERN DIGITAL CORP COM WDC WDC 1,132 $723.0k0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1k
61 SPDR SER TR S&P HOMEBUILD XHB XHB 6,000 $693.4k0.20% 0.20% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.0k
62 BIONTECH SE SPONSORED ADS BNTX BNTX 7,301 $679.4k0.20% 0.20% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 6.9k, Q2 2026 7.3k +411 +411 6.0%
63 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 21,669 $625.8k0.18% 0.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 21.7k
64 SPDR SER TR S&P INS ETF KIE KIE 10,000 $609.9k0.18% 0.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.0k
65 ORUKA THERAPEUTICS INC COM ORKA ORKA 6,315 $601.0k0.18% 0.18% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.1k, Q2 2026 6.3k +1.2k +1,168 22.7%
66 FRANKLIN TEMPLETON ETF TR FTSE TAIWAN FLTW FLTW 5,600 $591.0k0.17% 0.17% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 3.7k, Q2 2026 5.6k +1.9k +1,900 51.4%
67 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 1,035 $560.8k0.16% 0.16% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 527, Q2 2026 1.0k +508 +508 96.4%
68 SELECT SECTOR SPDR TR FINANCIAL XLF XLF 9,600 $514.7k0.15% 0.15% AddedShares held: Q3 2025 12.2k, Q4 2025 23.4k, Q1 2026 6.2k, Q2 2026 9.6k +3.4k +3,400 54.8%
69 SELECT SECTOR SPDR TR TECHNOLOGY XLK XLK 2,600 $495.4k0.15% 0.15% AddedShares held: Q3 2025 4.0k, Q4 2025 9.5k, Q1 2026 200, Q2 2026 2.6k +2.4k +2,400 1200.0%
70 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 5,427 $442.4k0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.4k
71 MARVELL TECHNOLOGY INC COM MRVL MRVL 1,474 $439.1k0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 27.4k, Q1 2026 0, Q2 2026 1.5k
72 ALUMIS INC COM ALMS ALMS 15,396 $433.2k0.13% 0.13% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 12.0k, Q2 2026 15.4k +3.4k +3,365 28.0%
73 ILLUMINA INC COM ILMN ILMN 2,368 $416.4k0.12% 0.12% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 3.0k, Q2 2026 2.4k -658 -658 -21.7%
74 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 3,298 $404.3k0.12% 0.12% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 9.3k, Q2 2026 3.3k -6.0k -6,036 -64.7%
75 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 39,233 $386.4k0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 39.2k
76 COGENT BIOSCIENCES INC COM COGT COGT 9,698 $375.3k0.11% 0.11% ReducedShares held: Q3 2025 16.1k, Q4 2025 7.4k, Q1 2026 13.8k, Q2 2026 9.7k -4.1k -4,086 -29.6%
77 HEWLETT PACKARD ENTERPRISE C COM HPE HPE 8,193 $369.6k0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.2k
78 CERTARA INC COM CERT CERT 54,326 $355.8k0.10% 0.10% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 54.3k
79 IMMUNOVANT INC COM IMVT IMVT 9,043 $348.4k0.10% 0.10% NewShares held: Q3 2025 0, Q4 2025 13.7k, Q1 2026 0, Q2 2026 9.0k
80 MICROCHIP TECHNOLOGY INC. COM MCHP MCHP 3,782 $344.9k0.10% 0.10% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.8k
81 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 9,829 $328.2k0.10% 0.10% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.8k
82 BIOLIFE SOLUTIONS INC COM NEW BLFS BLFS 11,612 $327.9k0.10% 0.10% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 11.6k
83 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 15,149 $324.9k0.10% 0.10% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 15.1k
84 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 50,615 $315.8k0.09% 0.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 50.6k
85 CRYOPORT INC COM PAR $0.001 CYRX CYRX 20,067 $315.1k0.09% 0.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 20.1k
86 BELITE BIO INC SPONSORED ADS BLTE BLTE 2,008 $309.2k0.09% 0.09% ReducedShares held: Q3 2025 0, Q4 2025 3.0k, Q1 2026 6.0k, Q2 2026 2.0k -4.0k -3,996 -66.6%
87 TAIWAN SEMICONDUCTOR MFG LTD SPONSORED ADS TSM TSM 640 $305.6k0.09% 0.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 640
88 10X GENOMICS INC CL A COM TXG TXG 7,725 $296.2k0.09% 0.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 7.7k
89 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 12,755 $278.8k0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 12.8k
90 YUM CHINA HLDGS INC COM YUMC YUMC 6,473 $264.6k0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.5k
91 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 13,489 $262.6k0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 13.5k
92 BIOAGE LABS INC COM BIOA BIOA 10,472 $256.7k0.08% 0.08% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 20.8k, Q2 2026 10.5k -10.3k -10,324 -49.6%
93 ALBERTSONS COS INC COMMON STOCK ACI ACI 18,689 $252.9k0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 18.7k
94 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 4,645 $249.3k0.07% 0.07% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.2k, Q2 2026 4.6k +455 +455 10.9%
95 TANGO THERAPEUTICS INC COM TNGX TNGX 7,658 $239.4k0.07% 0.07% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 20.5k, Q2 2026 7.7k -12.8k -12,805 -62.6%
96 ABSCI CORPORATION COM ABSI ABSI 19,712 $228.5k0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 19.7k
97 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 4,499 $228.3k0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.5k
98 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 15,112 $225.8k0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 15.1k
99 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 9,342 $225.0k0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.3k
100 MAZE THERAPEUTICS INC COM MAZE MAZE 7,465 $222.8k0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 7.5k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ASE TECHNOLOGY HLDG CO LTD ASX ASX 179,512 $3.9m179.5k shares
ASCENDIS PHARMA A/S 11,828 $2.7m11.8k shares
PFIZER INC PFE PFE 71,313 $2.0m71.3k shares
REGENERON PHARMACEUTICALS REGN REGN 2,502 $1.9m2.5k shares
JOHNSON & JOHNSON JNJ JNJ 7,902 $1.9m7.9k shares
AMGEN INC AMGN AMGN 4,934 $1.7m4.9k shares
GILEAD SCIENCES INC GILD GILD 11,961 $1.7m12.0k shares
VERTEX PHARMACEUTICALS INC VRTX VRTX 3,412 $1.5m3.4k shares
MICROCHIP TECHNOLOGY INC. MCHP 0.75 06.01.30 MCHP 0.75 06.01.30 1,500,000 $1.5m1.5m shares
AMBAC FINL GROUP INC OSG OSG 139,168 $647.1k139.2k shares
AXOGEN INC AXGN AXGN 16,273 $539.1k16.3k shares
SELECT SECTOR SPDR TR XLE XLE 8,500 $520.7k8.5k shares
GENMAB A/S GMAB GMAB 16,030 $430.1k16.0k shares
ERASCA INC ERAS ERAS 24,847 $402.0k24.8k shares
LUMENTUM HLDGS INC LITE LITE 562 $395.0k562 shares
APOGEE THERAPEUTICS INC 4,007 $337.3k4.0k shares
IMMUNITYBIO INC IBRX IBRX 41,005 $314.5k41.0k shares
DYNE THERAPEUTICS INC DYN DYN 17,213 $312.1k17.2k shares
SPYRE THERAPEUTICS INC SYRE SYRE 6,140 $309.7k6.1k shares
TYRA BIOSCIENCES INC TYRA TYRA 8,075 $309.3k8.1k shares
SPDR S&P 500 ETF TR SPY SPY 420 $273.1k420 shares
EQUITABLE HLDGS INC EQH EQH 6,794 $252.1k6.8k shares
SUMMIT THERAPEUTICS INC SMMT SMMT 12,136 $230.1k12.1k shares
ENVISTA HOLDINGS CORPORATION NVST NVST 9,001 $228.4k9.0k shares
CG ONCOLOGY INC CGON CGON 3,370 $228.1k3.4k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
VANECK ETF TRUST SMH · Call SMHCall 80,000 $52.5m80.0k shares New
SPDR S&P 500 ETF TR SPY · Call SPYCall 40,000 $29.9m40.0k shares New
ISHARES INC EWY · Put EWYPut 86,000 $17.3m86.0k shares New
ISHARES INC EWT · Put EWTPut 112,000 $12.2m112.0k shares New
ISHARES TR IGV · Call IGVCall 80,000 $7.2m80.0k shares Reduced